Please login to the form below

Not currently logged in
Email:
Password:

Phil Golz appointed commercial director at HealthUnlocked

Moves from ViiV Healthcare to join the socialnetwork for health

Health Unlocked Phil GolzHealth social network HealthUnlocked has appointed Phil Golz to the newly-created role of commercial director.

He joins the company from ViiV Healthcare, where he was executive director, and prior to that he served as head of commercial innovation at GlaxoSmithKline.

In his new role Golz will will be responsible for developing HealthUnlocked's commercial strategy and operations as part of a drive to accelerate its growth and create additional value for members and visitors.

Phil Golz said: "I'm absolutely thrilled to be joining HealthUnlocked at such an exciting time in their evolution. With its advanced technology and relentless focus on creating value for patients, I believe HealthUnlocked has great potential to transform healthcare and I look forward to helping them achieve this goal.

Formed in 2010, HealthUnlocked claims the title of the world's largest social network for health with more than 320,000 registered users who account for over 3.5 million visits to the site each month.

Jorge Armanet, CEO of HealthUnlocked, said: "Phil brings a great depth of knowledge and experience in all areas and angles of healthcare and an energy and fresh views that we are delighted to welcome into our team.

“It's an incredibly exciting time for our company whilst we are moving beyond the peer-to-peer support into a much more comprehensive set of patient services and we look forward to working with a broad range of healthcare players.

28th September 2015

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics